Efficacy, safety, and patient satisfaction with oral semaglutide: first single-centre clinical experience.

ABSTRACT:

Objective

To explore the effects of oral semaglutide on glycaemic parameters, body weight, and satisfaction in the first recipient patients with type 2 diabetes mellitus in Slovenia, in a real-world clinical practice setting.

Methods

The first consecutive adult patients with type 2 diabetes who were eligible for oral semaglutide treatment were included in this prospective, open-label interventional study. Patients received increasing doses of oral semaglutide and were evaluated at inclusion, at 1 month, then 3-5 months after starting treatment. Fasting blood glucose, glycosylated haemoglobin (HbA1c), body weight, patient satisfaction with oral semaglutide treatment (using the validated Treatment Satisfaction Questionnaire for Medication), and adverse effects, were analysed.

SUBMITTER: Janic M 

PROVIDER: S-EPMC10664446 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature